Megamont wins ₹3.74 crore order from Bunge India for soybean oil
- Megamont secured a ₹3.74 crore work order from Bunge India Pvt. Ltd.
- The contract covers procurement of 250 MT of Soyabean Refined Oil.
- Order value represents approximately 1.8% of average quarterly revenue.
- Disclosed order book coverage remains negligible at 0.00 quarters.

*this image is generated using AI for illustrative purposes only.
Megamont has received a confirmed work order valued at ₹3.74 crore from Bunge India Pvt. Ltd. The contract involves the procurement of 250 MT of Soyabean Refined Oil.
Order in Financial Context
The order value of ₹3.74 crore constitutes approximately 1.8% of the company's average quarterly revenue of ₹206.57 crore. The total disclosed order book, which sums exactly the same last 3 fiscal quarters shown in the order track record table below (sum of the 1 orders disclosed across the last 3 fiscal quarters shown in the table below), results in an order book coverage of 0.00 quarters of average quarterly revenue. Consequently, the book-to-bill ratio is negligible relative to the trailing twelve-month revenue base. This single contract does not materially alter the backlog profile or provide multi-quarter visibility at this stage.
Company Order Track Record
The company has disclosed only one significant order in the last three fiscal quarters. Inflow velocity appears low compared to the scale of annual operations, with no other major contracts recorded in the immediate history provided. The current order size is consistent with the limited data available, representing a standalone transaction without comparable historical benchmarks in the disclosed period.
| Quarter | Total Order Inflow (₹ Cr) | Key Awarding Entities |
|---|---|---|
| Q1FY27 (Apr-Jun 2026) | 0.00 | None |
| Q4FY26 (Jan-Mar 2026) | 0.00 | None |
| Q3FY26 (Oct-Dec 2025) | 0.00 | None |
Note: The current order date is Oct 07, 2026, falling into Q2FY27, which is not yet fully reported in the historical table above.
Execution and Revenue Quality
Recent quarterly performance shows a sequential decline in revenue, dropping from ₹316.90 crore in Q3FY26 to ₹219.40 crore in Q1FY27. Despite the revenue contraction, net profit remained positive across all three quarters, although operating profit margins fluctuated between 0.74% and 1.99%. The lack of loss-making quarters suggests stable execution quality, but the shrinking top line warrants monitoring for potential volume constraints.
| Quarter | Revenue (₹ Cr) | Net Profit (₹ Cr) | OPM (%) |
|---|---|---|---|
| Q1FY27 | 219.40 | 2.20 | 1.92% |
| Q4FY26 | 290.00 | 3.60 | 1.99% |
| Q3FY26 | 316.90 | 3.30 | 0.74% |
Revenue Growth: Order Wins Translating to Revenue
As Megamont has sustained minimal order disclosures in the recent period, its annual consolidated revenue grew from ₹0.00 crore in FY25 to ₹606.90 crore in FY26. This represents a non-comparable YoY growth metric due to the zero-base in the prior year, indicating a restart or reclassification of revenue streams rather than organic expansion from prior high bases.
Working Capital and Execution Capacity
The company maintains a Current Ratio of 1.69x and a Total Liabilities/Equity ratio of 1.59x, suggesting adequate liquidity buffers for short-term obligations. However, Operating Cashflow was negative at -₹68.90 crore in FY26, indicating that earnings are not efficiently converting to cash. This divergence between accrual-based profits and cash generation may signal stretched receivables or inventory build-up, impacting free cash flow capacity.
What to Watch
- Execution Rate: Monitor quarterly revenue run-rate against the ₹206.57 crore average; watch for stabilization after the Q1FY27 dip.
- Cash Conversion: Track if the negative operating cashflow trend reverses as new orders like the Bunge contract are executed.
- Client Concentration: Bunge India accounts for 100% of the disclosed order book in the tracked window, highlighting reliance on single-client inflows.
- Margin Trajectory: Observe if OPM sustains above 1.5% as the company scales down from previous quarter highs.
Key Observations
- Backlog signal: Book-to-bill coverage is effectively 0.00 quarters based on disclosed data; execution capacity is not currently constrained by backlog depth but by new order inflow.
- Cash conversion: Operating cashflow of -₹68.90 crore in FY26; backlog is not converting to cash efficiently, and receivables or working capital cycle may be stretched.
- Valuation check (as of 07 Oct 2026): P/E of 63.0x against ROCE of 26.01%. At the time of this article, valuation was pricing in execution improvement not yet visible in return ratios.
Historical Stock Returns for Megamont
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +9.98% | +25.39% | +33.37% | +74.04% | +470.76% | 0.0% |
Will Megamont secure additional orders in Q2FY27 to address the negligible book-to-bill ratio and provide multi-quarter revenue visibility?
How will the execution of the Bunge India contract impact Megamont's negative operating cash flow trend observed in FY26?
Can Megamont diversify its client base to mitigate the concentration risk associated with Bunge India comprising 100% of disclosed recent orders?

































